4 unknown. 4 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Unknown 4 |
| Phase 2 | 4 | Unknown 4 |
Follow Bendamustine: new trials by email Literature Review of Bendamustine trials Research Report on Bendamustine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Efficacy and Safety of Pomalidomide and Bendamustine With Dexamethasone in Relapsed or Refractory Multiple Myeloma Pomalidomide, Bendamustine, Dexamethasone - Relapsed, Refractory, Multiple Myeloma | Phase 1 / Phase 2 | Unknown | Sun Yat-sen University | 56 | 2021-02-01 | 2021-02-21 |
| Bendamustine + Pomalidomide + Dex in R/R Multiple Myeloma Bendamustine, Pomalidomide, Dexamethasone - Multiple Myeloma | Phase 1 / Phase 2 | Unknown | Cristina Gasparetto | 56 | 2013-01-07 | 2024-02-20 |
| A Phase 1/2 Study of Lenalidomide in Combination With Bendamustine in Relapsed and Primary Refractory Hodgkin Lymphoma Lenalidomide, Bendamustine, Bio-specimen Retention - Recurrent Adult Hodgkin Lymphoma | Phase 1 / Phase 2 | Unknown | Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale | 36 | 2011-07-01 | 2015-08-11 |
| Study of Bendamustine, Lenalidomide and Low-dose Dexamethasone, for the Treatment of Patients With Relapsed Myeloma Bendamustine, Lenalidomide, Dexamethasone - Multiple Myeloma | Phase 1 / Phase 2 | Unknown | Gruppo Italiano Studio Linfomi | 60 | 2010-02-01 | 2013-04-05 |
Multiple Myeloma (3) · Recurrence (2) · Hodgkin Disease (1)
Cristina Gasparetto (1) · Gruppo Italiano Studio Linfomi (1) · Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale (1) · Sun Yat-sen University (1)
Italy (2) · China (1) · United States (1)
Antonio Pinto, MD (1) · Fortunato Morabito, MD (1) · Gaetano Corazzelli, MD (1) · Gwynn Long, MD (1)